01533nam 2200397Ia 450 991069883390332120090526104004.0(CKB)5470000002397528(OCoLC)351399149(EXLCZ)99547000000239752820090526d2003 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] notifying FDA of fatalities related to blood collection or transfusionRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2003]5 pages digital, PDF fileTitle from PDF title page (viewed on May 26, 2009)."Final guidance"."September 2003".Guidance for industry BloodTransfusionGovernment policyUnited StatesBloodCollection and preservationGovernment policyUnited StatesDeath notificationGovernment policyUnited StatesBloodTransfusionGovernment policyBloodCollection and preservationGovernment policyDeath notificationGovernment policyCenter for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698833903321Guidance for industry3434577UNINA